Domus Diagnostics
PrivateLast Round
Grant
May 24, 2023
Total Funding Raised
$3.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Domus Diagnostics operates in Healthcare & Life Sciences and is based in Park City, Utah. Its latest recorded funding round was a Grant round in May 2023.
Domus Diagnostics is a diagnostic equipment company that develops affordable, user-friendly, and rapid at-home and point-of-care molecular diagnostic tests for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Domus Diagnostics Comparables
Compare Domus Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seek Labs | 78% | |
| Llusern Scientific | 77% | |
| OraSure Technologies Inc | 77% |
For institutional investors. Book with your work email.
Domus Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 24, 2023 | ||||
| Seed | Apr 20, 2022 |
For institutional investors. Book with your work email.
Domus Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| NIH RADx | Grant |
| Bantam Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 49% MoM, reaching 1.6K.
- Jul 25, 2026
Monthly visitors grew 296% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Domus Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Domus Diagnostics's valuation, stock price, and market status.
Is Domus Diagnostics a public or private company?
Domus Diagnostics is a private company.
What is the current stock price of Domus Diagnostics?
Domus Diagnostics is a private company, so its shares have no public market price. Caplight tracks Domus Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Domus Diagnostics worth (valuation)?
Valuation information for Domus Diagnostics is not publicly available.
Can I buy Domus Diagnostics stock?
Domus Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Domus Diagnostics's last funding round?
Domus Diagnostics's most recent funding round was Grant on May 24, 2023.
Who are the main investors in Domus Diagnostics?
Key investors in Domus Diagnostics include National Institute of Biomedical Imaging and Bioengineering, NIH RADx, Bantam Group.
Will Domus Diagnostics IPO soon?
No public IPO plans have been announced for Domus Diagnostics.
How can I track Domus Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Domus Diagnostics's shares on secondary markets.